AUSDRISK category | ||||||
---|---|---|---|---|---|---|
0–5 | 6–8 | 9–11 | 12–15 | 16–19 | 20–36 | |
Annual incidence of type 2 diabetes (%) | 0.2 | 0.4 | 0.7 | 1.5 | 3.0 | 7.8 |
Males | ||||||
Number of observations (%) | 10 (1.8) | 77 (13.7) | 180 (32.1) | 134 (23.9) | 107 (19.1) | 53 (9.5) |
Age (years) | 41.8 | 47.8 | 57.2 | 61.0 | 61.5 | 65.5 |
Weight (kg) | 87.7 | 81.5 | 81.6 | 84.5 | 97.2 | 105.1 |
BMI (kg/m2) | 27.9 | 26.1 | 26.6 | 27.6 | 31.5 | 34.6 |
Waist circumference (cm) | 92.2 | 91.6 | 94.4 | 98.8 | 110.6 | 118.8 |
FPG (mmol/L) | 5.2 | 5.2 | 5.2 | 5.3 | 5.6 | 5.8 |
Total cholesterol (mmol/L) | 5.2 | 5.7 | 5.6 | 5.4 | 5.1 | 5.0 |
HDL (mmol/L) | 1.4 | 1.4 | 1.4 | 1.3 | 1.2 | 1.2 |
LDL (mmol/L) | 3.2 | 3.6 | 3.5 | 3.3 | 3.1 | 2.9 |
Triglycerides (mmol/L) | 1.3 | 1.5 | 1.6 | 1.7 | 1.9 | 2.0 |
Systolic BP (mm Hg) | 120.4 | 124.5 | 130.2 | 137.2 | 143.2 | 149.3 |
Diastolic BP (mm Hg) | 79.3 | 80.3 | 79.3 | 79.4 | 82.4 | 84.0 |
MetS (%) | 11.1 | 14.7 | 26.8 | 41.6 | 64.9 | 83.3 |
Females | ||||||
Number of observations (%) | 98 (15.6) | 161 (25.6) | 117 (18.6) | 154 (24.5) | 75 (11.9) | 23 (3.7) |
Age (years) | 46.3 | 56.1 | 56.7 | 61.3 | 61.6 | 65.0 |
Weight (kg) | 65.2 | 67.5 | 74.1 | 80.0 | 88.8 | 92.4 |
BMI (kg/m2) | 24.2 | 25.6 | 28.1 | 30.7 | 34.0 | 36.5 |
Waist circumference (cm) | 77.8 | 81.6 | 88.0 | 96.9 | 104.6 | 113.2 |
FPG (mmol/L) | 4.9 | 5.0 | 5.1 | 5.2 | 5.5 | 5.7 |
Total cholesterol (mmol/L) | 5.1 | 5.8 | 5.5 | 5.9 | 5.5 | 5.3 |
HDL (mmol/L) | 1.8 | 1.8 | 1.6 | 1.6 | 1.4 | 1.4 |
LDL (mmol/L) | 2.8 | 3.4 | 3.2 | 3.5 | 3.2 | 3.1 |
Triglycerides (mmol/L) | 1.0 | 1.2 | 1.5 | 1.8 | 1.9 | 1.9 |
Systolic BP (mm Hg) | 117.0 | 126.3 | 132.0 | 137.8 | 141.1 | 141.2 |
Diastolic BP (mm Hg) | 71.7 | 74.3 | 77.3 | 76.7 | 77.8 | 73.4 |
MetS (%) | 4.4 | 11.8 | 28.3 | 53.1 | 64.7 | 89.5 |
AUSDRISK, Australian Type 2 Diabetes Risk Assessment Tool; BMI, body mass index; BP, blood pressure; FPG, fasting plasma glucose; GGT RFS, Greater Green Triangle Risk Factor Study; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MetS, metabolic syndrome.